This content is only available within our institutional offering.
08 Jan 2020
Healthcare Top Picks Q1 2020 Healthcare: Astrazeneca, Genfit, Korian, Roche
Roche Holding Ltd Dividend Right Cert. (RHO5:ETR), 0 | Clariane SE (CLARI:PAR), 0 | Genfit SA (GNFT:PAR), 0 | AstraZeneca PLC (AZN:LON), 11,977 | AstraZeneca PLC (AZN:LON), 11,977
Sign in
This content is only available to commercial clients. Sign in if you have access or contact support@research-tree.com to set up a commercial account
This content is only available to commercial clients. Sign in if you have access or contact support@research-tree.com to set up a commercial account
Healthcare Top Picks Q1 2020 Healthcare: Astrazeneca, Genfit, Korian, Roche
Roche Holding Ltd Dividend Right Cert. (RHO5:ETR), 0 | Clariane SE (CLARI:PAR), 0 | Genfit SA (GNFT:PAR), 0 | AstraZeneca PLC (AZN:LON), 11,977 | AstraZeneca PLC (AZN:LON), 11,977
- Published:
08 Jan 2020 -
Author:
Bruno de La Rochebrochard -
Pages:
4
Healthcare
Top Picks Q1 2020 Healthcare: Astrazeneca, Genfit, Korian, Roche
Looking back to Q4 2019 and 2019 as a whole
What is ahead of us in Q1 2020